69 results
Page 3 of 4
8-K
EX-10.1
idmw3o kujbx41auwc
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
8-K
EX-2.1
6qv5lwa7ye6u
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
8-K
r9r422hb4pu a2uac0
2 Sep 20
NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors
8:57am
8-K/A
lx006e1
7 Jan 20
Changes in Registrant's Certifying Accountant
10:27am
8-K
lgv47i3vrdr oizi
30 Dec 19
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals
9:04pm
424B3
ehaa5cvlu gcupq140b
6 Nov 19
Prospectus supplement
9:15am
425
EX-3.1
wnngy
30 Oct 19
Business combination disclosure
12:00am
8-K
EX-3.1
nn1orubk4p2
30 Oct 19
Entry into a Material Definitive Agreement
12:00am
S-4/A
4b4xd
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4
EX-10.42
j7sz5inj
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
eeninpib
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.43
lkvmj6b2gylxqwwp651
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
8-K
EX-10.6
l9pvh5ms egsb2g
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am